Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

73.49 +0.45 (+0.62%)

Streaming Delayed Price Updated: 11:21 AM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

46 47 Next >

DXCM Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)

November 04, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

DexCom (DXCM) Stock Is Up, What You Need To Know

November 03, 2025

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 3.7% in the afternoon session after it rebounded from a steep sell-off that was triggered by its long-term revenue growth outlook. The stock...

Via StockStory

Topics Earnings

These S&P500 stocks have an unusual volume in today's session ↗

November 03, 2025

Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.

Via Chartmill

Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup ↗

October 30, 2025

Via Stocktwits

Exploring the top movers within the S&P500 index during today's session. ↗

November 03, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Class Action Announcement DXCM: A Securities Fraud Class Action Lawsuit Was Filed Against DexCom, Inc. (DXCM)

November 03, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Class Action Announcement DXCM: A Securities Fraud Class Action Lawsuit Was Filed Against DexCom, Inc. (DXCM)

November 03, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

AI's Power Problem ↗

November 03, 2025

AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast?

Via The Motley Fool

Topics Artificial Intelligence Economy Energy

Fiserv, eBay, And Garmin Are Among Top 10 Large Cap Losers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? ↗

November 02, 2025

These ten large-cap stocks led last week's declines, including Fiserv, Alexandria Real Estate, Chipotle, eBay, after weak results and guidance.

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

October 31, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

Discover which S&P500 stocks are making waves on Friday. ↗

October 31, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday? ↗

October 31, 2025

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.

Via Benzinga

Why DexCom (DXCM) Stock Is Falling Today

October 31, 2025

Shares of medical device company DexCom (NASDAQ:DXCM) fell 14.8% in the afternoon session after the company reported underwhelming earnings.

Via StockStory

Topics Artificial Intelligence Economy Government

Why DexCom Stock Is Crashing Today ↗

October 31, 2025

The diabetes equipment provider had a strong quarter, but next year is looking weaker than expected.

Via The Motley Fool

Topics Earnings

DXCM Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc.

October 31, 2025

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Gapping S&P500 stocks in Friday's session ↗

October 31, 2025

Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); DexCom, Inc. (NASDAQ: DXCM); Humana Inc. (NYSE: HUM); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf

October 31, 2025

From Grabar Law Office

Via GlobeNewswire

Top S&P500 movers in Friday's pre-market session ↗

October 31, 2025

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

DXCM Q3 Deep Dive: Margin Pressures Offset Strong Diabetes Access and Product Expansion

October 31, 2025

Medical device company DexCom (NASDAQ:DXCM) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s...

Via StockStory

Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook ↗

October 31, 2025

Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.

Via Investor's Business Daily

Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

October 31, 2025

Via Benzinga

These S&P500 stocks are moving in today's after hours session ↗

October 30, 2025

As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.

Via Chartmill

DexCom Inc (NASDAQ:DXCM) Reports Q3 2025 Earnings Beat Amid Stock Plunge on Guidance Concerns ↗

October 30, 2025

DexCom Q3 2025 earnings beat estimates, but stock fell due to full-year revenue guidance that missed analyst expectations.

Via Chartmill

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 30, 2025

Via Benzinga

DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops

October 30, 2025

Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be...

Via StockStory

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

October 30, 2025

From DexCom, Inc.

Via Business Wire

What Does the Market Think About DexCom Inc? ↗

October 30, 2025

Via Benzinga

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. and Certain Officers – DXCM

October 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Should You Buy DexCom Stock Before Oct. 31? ↗

October 30, 2025

The company hasn't had a great year. Is it about to turn things around?

Via The Motley Fool

Topics Lawsuit

< Previous 1 2 3 4 5 6 7 8 9

...

46 47 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.